SciVac Therapeutics Inc

(SVACF)

By |

Profile

VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.

Contact Information

Website: www.vbivaccines.com
Email: ir@vbivaccines.com
Main Phone: +1 617 830-3031
Address: 222 Third Street
Address 2: Suite 2241
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: OTCQX
CEO: Jeff Baxter
Employees: 103
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 17.45 52 Wk Low 3.40
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 66,678,473.00 EPS (TTM) -0.89 PE Ratio N/A Exchange OTCQX